Xiaolu Duan

8PUBLICATIONS
7CO-AUTHORS
PharmacogenomicsSport and exercise nutritionCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEnvironmental biogeochemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 25, 2026
Preclinical Assessment of HLA-A*02:01-Restricted PSMA and STEAP1 Epitopes for Peptide-Based Immunotherapy in Prostate Cancer.

Yueting Huang, Yang Yang, Yanni Xie

|Aug 25, 2025
Human fecal microbiota transplantation attenuates high dietary oxalate-induced renal calcium oxalate crystal depositions in rats via repairing Allobaculum-related gut barrier damage.

Yuhao Zhou, Min Lei, Weihong Cai

|Aug 12, 2025
The Contradictory Effects of SPTLC1 on Clear Cell Renal Carcinoma Sensitivity to Sunitinib Mediated by Androgen Receptor.

Liqiong Liao, Zhixiong Zhang, Zhenhua Li

|Feb 16, 2024
EMX2 inhibits clear cell renal cell carcinoma progress via modulating Akt/FOXO3a pathway.

Xiaofeng Zhou, Sicheng Dong, Yuhao Zhou

|Aug 02, 2021
Escherichia coli Aggravates Calcium Oxalate Stone Formation via PPK1/Flagellin-Mediated Renal Oxidative Injury and Inflammation.

Lingyue An, Weizhou Wu, Shujue Li

|Jun 18, 2020
Prostate cancer patients can benefit from 5-alpha-reductase inhibitor treatment: a meta-analysis.

Tuo Deng, Xueming Lin, Xiaolu Duan

Pageof 2

Frequent Collaborators

2 joint publications

Lingyue An

1 joint publications

Tuo Deng

1 joint publications

Wenqi Wu

1 joint publications

Liqiong Liao